Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray (NASDAQ: ARAY) announced inducement equity awards to new CEO Stephen La Neve effective October 31, 2025, granted outside the company’s existing equity plan under NASDAQ Rule 5635(c)(4).
The board approved 1,500,000 restricted stock units vesting 25% annually over four years and 1,500,000 performance-based restricted stock units (PSUs) tied to VWAP stock-price goals over an approximately six-year performance period ending September 30, 2031. PSUs are split into three tranches with specific price targets and dated vesting cutoffs in 2027, 2029, and 2031.
Accuray (NASDAQ: ARAY) ha annunciato premi azionari di induzione al nuovo CEO Stephen La Neve efficaci il 31 ottobre 2025, concessi al di fuori del piano azionario esistente della società secondo la Regola NASDAQ 5635(c)(4).
Il consiglio ha approvato 1.500.000 unità azionarie soggette a restrizioni che maturano al 25% annualmente per quattro anni e 1.500.000 unità azionarie soggette a performance (PSU) legate a obiettivi di prezzo VWAP su un periodo di performance di circa sei anni che termina il 30 settembre 2031. Le PSU sono suddivise in tre tranche con target di prezzo specifici e date di vesting fissate nel 2027, 2029 e 2031.
Accuray (NASDAQ: ARAY) anunció premios de acciones de inducción para el nuevo CEO Stephen La Neve con efecto a partir del 31 de octubre de 2025, otorgados fuera del plan de acciones existente de la empresa según la Regla NASDAQ 5635(c)(4).
La junta aprobó 1.500.000 unidades de acciones restringidas que se consolidan en un 25% anual durante cuatro años y 1.500.000 unidades de acciones restringidas basadas en desempeño (PSUs) vinculadas a metas de precio de VWAP durante un periodo de desempeño de aproximadamente seis años que termina el 30 de septiembre de 2031. Las PSUs se dividen en tres tramos con objetivos de precio específicos y fechas de consolidación datadas en 2027, 2029 y 2031.
Accuray (NASDAQ: ARAY)은 신규 CEO Stephen La Neve에 대한 인센티브 주식 수여를 2025년 10월 31일부로 발효시키며, NASDAQ 규정 5635(c)(4)에 따라 회사의 기존 주식계획 외부에서 부여되었습니다.
이사회는 1,500,000주식 제한 주식 단위를 승인하여 4년 동안 매년 25%가 베스팅되며, 1,500,000주식 성과기반 제한 주식 단위(PSU)를 VWAP 주가 목표에 연동하여 약 6년의 수행 기간 동안 2031년 9월 30일에 종료됩니다. PSU는 특정 가격 목표와 2027년, 2029년, 2031년에 정해진 베스팅 날짜로 세 구간으로 나뉩니다.
Accuray (NASDAQ: ARAY) a annoncé des attributions d’actions d’incitation au nouveau PDG Stephen La Neve à effet le 31 octobre 2025, accordées en dehors du plan d’actionnariat existant de la société en vertu de la Règle NASDAQ 5635(c)(4).
Le conseil d’administration a approuvé 1 500 000 unités d’actions restreintes qui vestent à raison de 25 % par an sur quatre ans et 1 500 000 unités d’actions restreintes basées sur la performance (PSU) liées à des objectifs de prix VWAP sur une période de performance d’environ six ans se terminant le 30 septembre 2031. Les PSU sont divisées en trois tranches avec des objectifs de prix spécifiques et des dates d’acquisition datées en 2027, 2029 et 2031.
Accuray (NASDAQ: ARAY) kündigte inducement equity awards für den neuen CEO Stephen La Neve an, mit Wirkung zum 31. Oktober 2025, gewährt außerhalb des bestehenden Aktienplans des Unternehmens gemäß NASDAQ-Regel 5635(c)(4).
Der Vorstand genehmigte 1.500.000 Restricted Stock Units, die jährlich zu 25% über vier Jahre vesten, sowie 1.500.000 Performance-basierte Restricted Stock Units (PSUs), die an VWAP-Preisziele gebunden sind und über einen ungefähr sechsjährigen Leistungszeitraum bis zum 30. September 2031 enden. Die PSUs sind in drei Tranchen unterteilt mit spezifischen Preiszielen und datierten Vesting-Fällen in 2027, 2029 und 2031.
Accuray (NASDAQ: ARAY) أعلنت منح مكافآت أسهم تحفيزية للرئيس التنفيذي الجديد Stephen La Neve اعتباراً من 31 أكتوبر 2025، مُنحت خارج خطة الأسهم الحالية للشركة وفقاً لقاعدة NASDAQ 5635(c)(4).
وافق مجلس الإدارة على 1,500,000 وحدة أسهم مقيدة التي تتحقق بنسبة 25% سنوياً على مدى أربع سنوات و1,500,000 وحدة أسهم مقيدة قائمة على الأداء (PSUs) مرتبطة بأهداف سعر VWAP خلال فترة أداء تقارب ست سنوات وتنتهي في 30 سبتمبر 2031. تقسم PSUs إلى ثلاث شرائح مع أهداف سعر محددة وتواريخ تقنين موثوق في 2027 و2029 و2031.
- New CEO hire accompanied by 3,000,000 total equity awards
- RSUs vest 25% annually, supporting multi‑year retention
- PSUs tie pay to sustained stock-price performance goals through 2031
- Potential future issuance of 3,000,000 shares if awards vest
- PSU performance period runs to Sept 30, 2031, delaying full shareholder alignment
- Early-vesting caps limit accelerated PSU vesting to 1/3 first year and 2/3 by second year
Insights
CEO inducement awards granted: large equity package with time- and price-based vesting through
The Board granted Stephen La Neve 1,500,000 restricted stock units and 1,500,000 performance-based restricted stock units, effective
The structure aligns a substantial portion of pay to future share-price performance over an extended period ending
Twenty-five percent of the restricted stock units subject to the restricted stock unit award will vest on each anniversary of October 31, 2025, subject to Mr. La Neve's continued service through each applicable vesting date.
The PSU award is eligible to vest based on the company's stock price performance over an approximately six-year performance period ending September 30, 3031. The PSU award is divided into three tranches. Each tranche is eligible to vest one year after the achievement of a stock price goal, measured based on the volume weighted average price of the company's common stock ("VWAP") over a trailing, consecutive 30-day trading day period, as compared to a starting price equal to the VWAP over a trailing, consecutive 30-day trading day period prior to October 20, 2025 (the "Starting Price"), Mr. La Neve's employment start date. The stock price goals and number of PSUs eligible to vest per tranche are as follows: (i) 375,000 PSUs are eligible to vest upon the achievement of a stock price goal on or prior to September 30, 2027 equal to the greater of
About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Media Contact
Beth Kaplan
Public Relations Director, Accuray
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-incorporated-reports-inducement-award-under-nasdaq-listing-rules-302601233.html
SOURCE Accuray Incorporated